Evidence map›Paper›PMID 33347710›Full record

ArticleMicrobial biotechnology2021

Identification of Collimonas gene loci involved in the biosynthesis of a diffusible secondary metabolite with broad-spectrum antifungal activity and plant-protective properties.

Fidele N Akum, Ravi Kumar, Gary Lai, Catherine H Williams, Hung K Doan, Johan H J Leveau

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in microbiology · 2025
    Article
  4. Draft genome sequence ofMicrobiology resource announcements · 2024
    Article
  5. International journal of systematic and evolutionary microbiology · 2024
    Article
  6. Article
  7. Article
  8. Activity of Fengycin and Iturin A Isolated FromFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Fidele N AkumDepartment of Plant Pathology, University of California Davis, Davis, CA, USA.
Ravi KumarNovozymes Inc, 1445 Drew Avenue, Davis, CA, USA.
Gary LaiNovozymes Inc, 1445 Drew Avenue, Davis, CA, USA.
Catherine H WilliamsDepartment of Plant Pathology, University of California Davis, Davis, CA, USA.
Hung K DoanDepartment of Plant Pathology, University of California Davis, Davis, CA, USA.
Johan H J LeveauDepartment of Plant Pathology, University of California Davis, Davis, CA, USA.ORCID 0000-0002-8376-4553
University of California, Davis · USNovozymes (United States) · US

Funding

Novozymes North America, Inc.
6 · The paper itself

Abstract

In greenhouse and field trials, a bacterial mixture of Collimonas arenae Cal35 and Bacillus velezensis FZB42, but not Cal35 alone or FZB42 alone, was able to protect tomato plants from challenge with the soilborne fungal pathogen Fusarium oxysporum f.sp. lycopersici (Fol). To identify genes and mechanisms underlying this property in Cal35, we screened a random transposon insertion library for loss of function and identified two mutants that were impaired completely or partially in their ability to halt the growth of a wide range of fungal species. In mutant 46A06, the transposon insertion was located in a biosynthetic gene cluster that was predicted to code for a hybrid polyketide synthase-non-ribosomal peptide synthetase, while mutant 60C09 was impacted in a gene cluster for the synthesis and secretion of sugar repeat units. Our data are consistent with a model in which both gene clusters are necessary for the production of an antifungal compound we refer to as carenaemins. We also show that the ability to produce carenaemin contributed significantly to the observed synergy between Cal35 and FZB42 in protecting tomato plants from Fol. We discuss the potential for supplementing Bacillus-based biocontrol products with Collimonas bacteria to boost efficacy of such products.

Indexed as

FusariumSolanum lycopersicumAntifungal AgentsBacillusOxalobacteraceaePlant DiseasesAntifungal Agents

Identifiers

PMID33347710
PMCPMC8313283
OpenAlexW3116253676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.